Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Guided Bone Regeneration Membrane Materials Loaded with Chimeric Nanovesicles Promote Early Bone Defect Regeneration.

Zhang Y., Wang Y., Ning X., Yue G., Zhang W., Chen Y.

Animal Study, published in Adv Healthc Mater (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Adv Healthc Mater (2025)
Country
Germany
Reported sample size
—
Source database
PubMed
PMID
40879089
PMCID
PMC12716199
DOI
10.1002/adhm.202501323
Citations
3

Abstract (original English)

Early bone defect regeneration remains a major clinical challenge owing to a compromised osteogenic microenvironment characterized by insufficient mineralization and immature collagen deposition, which severely impede mechanical stability. Although conventional guided bone regeneration (GBR) membranes provide passive barrier functions, their lack of dynamic immune response regulation often leads to delayed ossification. To address this critical gap, a plasma-treated polycaprolactone (PT-PCL) electrospun nanofiber membrane functionalized with ultrasound sequentially extruded stromal vascular fraction chimeric vesicles (USE-SCNVs) is developed. The ultrasound-sequential extrusion approach requires less equipment, is faster, and holds greater potential for clinical application than traditional extrusion methods. Compared with nanovesicles formed by simple adipose-derived stem cells, these nanovesicles are more efficiently internalized by macrophages and are enriched with miRNAs, s uch as miR-30b, which promote rapid M2 macrophage polarization. In vivo experiments demonstrated that the nanofiber membranes loaded with USE-SCNVs can promote the rapid formation and maturation of new bone in the bone defect area within 2 weeks, forming primarily mature bone with increased platelet-like bone density.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Bone RegenerationAnimalsNanofibersPolyestersMiceMacrophagesOsteogenesisGuided Tissue RegenerationMembranes, ArtificialHumans

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.